Qi Xu
China Jiliang University(CN)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Cholangiocarcinoma and Gallbladder Cancer Studies, Pancreatic and Hepatic Oncology Research, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Treatments and Studies
Most-Cited Works
- → Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation(2013)90 cited
- → Meta‐analysis: Circulating adiponectin levels and risk of colorectal cancer and adenoma(2011)85 cited
- → Inhibition of PTP1B blocks pancreatic cancer progression by targeting the PKM2/AMPK/mTOC1 pathway(2019)84 cited
- → The MST4–MOB4 complex disrupts the MST1–MOB1 complex in the Hippo–YAP pathway and plays a pro-oncogenic role in pancreatic cancer(2018)71 cited
- → Architecture, substructures, and dynamic assembly of STRIPAK complexes in Hippo signaling(2019)68 cited
- → Enhanced Production of IL-10 by Dendritic Cells Deficient in CIITA(2005)57 cited
- → Phase 1b/2 trial of fruquintinib plus sintilimab in treating advanced solid tumours: The dose-escalation and metastatic colorectal cancer cohort in the dose-expansion phases(2022)51 cited
- → The expression of CXCL12 and CXCR4 in gastric cancer and their correlation to lymph node metastasis(2011)51 cited
- → Predictive and prognostic roles of BRAF mutation in patients with metastatic colorectal cancer treated with anti‐epidermal growth factor receptor monoclonal antibodies: A meta‐analysis(2013)44 cited
- → miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4(2017)38 cited